PMID: 22361784Jul 1, 2011Paper

The relationship between symptomatology and treatment selection in metastatic castrate-resistant prostate cancer

Clinical Advances in Hematology & Oncology : H&O
Eric J SmallOliver Sartor

Abstract

Metastatic castrate-resistant prostate cancer (CRPC) can occur in a patient with de novo metastatic disease who has received androgen-deprivation therapy. The initial evaluation of a patient who may have CRPC should include measurement of testosterone levels at the time of progression to confirm the presence of castrate levels of testosterone. Components of the workup include a baseline bone scan, a computed tomography scan, and a full blood panel. The follow-up of patients with metastatic CRPC should include measurement of prostate-specific antigen (PSA) levels as well as imaging studies. The most important clinical endpoint for these patients is survival, but others include symptoms, such as pain and fatigue; biochemical factors; and radiographic progression. Physicians must help manage symptoms, regardless of whether they arise from the treatment or the disease itself. For patients with metastatic CRPC, choice of treatment is driven primarily by whether the patient has asymptomatic or minimally symptomatic, versus symptomatic, disease. In this clinical roundtable monograph, experts discuss the diagnosis, prognosis, and management of patients with CRPC, with a focus on the best utilization of 4 recently approved agents: abira...Continue Reading

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.